ArticleDiscover oncology2025

CEG-0598, a novel dual inhibitor of EGFR and C5aR demonstrates in vitro anticancer and antimetastatic activity in prostate cancer cells.

Ayed A Dera et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.